- Report
- July 2024
- 139 Pages
Global
From €2283EUR$2,500USD£1,953GBP
- Report
- December 2024
- 150 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- April 2025
- 182 Pages
Global
From €4521EUR$4,950USD£3,866GBP
- Report
- February 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- January 2025
- 129 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- August 2024
- 137 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- October 2024
- 200 Pages
Global
From €4520EUR$4,949USD£3,865GBP
- Report
- July 2024
- 124 Pages
North America
From €2739EUR$2,999USD£2,342GBP
- Report
- August 2024
- 180 Pages
Asia Pacific
From €3534EUR$3,869USD£3,022GBP
- Report
- November 2023
- 124 Pages
Global
From €2055EUR$2,250USD£1,757GBP
€4110EUR$4,500USD£3,515GBP
- Report
- January 2023
- 124 Pages
Global
From €2055EUR$2,250USD£1,757GBP
- Report
- October 2021
- 120 Pages
Global
From €2283EUR$2,500USD£1,953GBP
- Report
- October 2020
- 120 Pages
Global
From €2283EUR$2,500USD£1,953GBP
- Report
- November 2022
- 113 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- August 2022
- 120 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,105USD£3,098GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$4,105USD£3,098GBP

The Mono Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Mono Vaccines are a type of vaccine that protect against a single pathogen, such as measles, mumps, rubella, or varicella. These vaccines are typically administered to children and are often combined with other vaccines to form a combination vaccine. Mono Vaccines are typically administered in a single dose, and are often given in combination with other vaccines to form a combination vaccine.
The Mono Vaccine market is highly competitive, with a number of companies offering products. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Other companies in the market include AstraZeneca, CSL, Emergent BioSolutions, and Johnson & Johnson. Show Less Read more